including Blueprint Medicines Corporation’s promising pipeline and financial strength. The company’s recent corporate update highlighted significant milestones and potential market ...

The soil on every inch of the pipeline would be tested to figure out which design worked best. The designers determined that they pipe could be buried in three types of ground: permanently thawed ...

Beyond Ayvakit, Blueprint Medicines is advancing several promising candidates in its pipeline. Of particular interest is BLU-808, an oral wild-type KIT inhibitor that has shown encouraging results ...